YU13794A - Nova jedinjenja polijodida, njihovo pripremanje i njihova primena kao kontrast za rendgenska snimanja - Google Patents

Nova jedinjenja polijodida, njihovo pripremanje i njihova primena kao kontrast za rendgenska snimanja

Info

Publication number
YU13794A
YU13794A YU13794A YU13794A YU13794A YU 13794 A YU13794 A YU 13794A YU 13794 A YU13794 A YU 13794A YU 13794 A YU13794 A YU 13794A YU 13794 A YU13794 A YU 13794A
Authority
YU
Yugoslavia
Prior art keywords
approximately
pct
compounds
weight
polyodid
Prior art date
Application number
YU13794A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
D. Meyer
S. Le Greneur
G. Le Lem
Ch. Simonot
C. Chambon
Original Assignee
Guerbet, J.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet, J.A. filed Critical Guerbet, J.A.
Publication of YU13794A publication Critical patent/YU13794A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polyamides (AREA)
  • Medicinal Preparation (AREA)
YU13794A 1993-03-22 1994-03-22 Nova jedinjenja polijodida, njihovo pripremanje i njihova primena kao kontrast za rendgenska snimanja YU13794A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303269A FR2703055B1 (fr) 1993-03-22 1993-03-22 Nouveaux composés polyiodés, leur préparation et leur utilisation en tant que produits de contraste pour la radiologie .

Publications (1)

Publication Number Publication Date
YU13794A true YU13794A (sh) 1997-08-22

Family

ID=9445205

Family Applications (1)

Application Number Title Priority Date Filing Date
YU13794A YU13794A (sh) 1993-03-22 1994-03-22 Nova jedinjenja polijodida, njihovo pripremanje i njihova primena kao kontrast za rendgenska snimanja

Country Status (16)

Country Link
US (1) US5817873A (no)
EP (1) EP0648203B1 (no)
JP (1) JPH07507572A (no)
AT (1) ATE173462T1 (no)
AU (1) AU6285594A (no)
CA (1) CA2136243A1 (no)
DE (1) DE69414678T2 (no)
ES (1) ES2126101T3 (no)
FI (1) FI945464A0 (no)
FR (1) FR2703055B1 (no)
HU (1) HU218083B (no)
IL (1) IL108967A (no)
NO (1) NO307962B1 (no)
WO (1) WO1994021600A1 (no)
YU (1) YU13794A (no)
ZA (1) ZA941959B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344464A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kaskadenpolymere mit Iodaromaten
AU3524295A (en) * 1994-09-22 1996-04-09 Guerbet S.A. Iodinated derivatives, preparation and use thereof as contrast agents in x-ray radiology
US5851511A (en) * 1994-09-22 1998-12-22 Guerbet S.A. Polyiodo compounds, their preparation and their use in X-ray radiology
US5756066A (en) * 1995-06-07 1998-05-26 Schering Aktiengesellschaft Iodine-containing peptides
WO2007055580A1 (en) * 2005-11-10 2007-05-18 Ge Healthcare As Contrast agents and diagnostic compositions based on iodine-containing cyanuric acid derivatives
NO20055702D0 (no) 2005-12-02 2005-12-02 Amersham Health As Contrast agents
US20070148096A1 (en) * 2005-12-15 2007-06-28 Lars-Goran Wistrand Contrast Agents
ES2396567T3 (es) 2006-02-14 2013-02-22 Ge Healthcare As Agentes de contraste
JP5248330B2 (ja) * 2006-02-14 2013-07-31 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
DE602007012208D1 (de) * 2006-02-15 2011-03-10 Ge Healthcare As Kontrastmittel
WO2007133090A1 (en) * 2006-05-11 2007-11-22 Ge Healthcare As Contrast agents
JP5345523B2 (ja) * 2006-05-11 2013-11-20 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
US7662859B2 (en) * 2007-02-16 2010-02-16 Ge Healthcare As Contrast agents
WO2008123779A1 (en) * 2007-04-04 2008-10-16 Ge Healthcare As Trisubstituted triazamacrocycli c compounds and their use as contrast agents
US20080260651A1 (en) * 2007-04-17 2008-10-23 Ge Healthcare As Contrast agents
NO20073382L (no) * 2007-06-29 2008-12-30 Ge Healthcare As Contrast Agents
KR101734955B1 (ko) 2008-11-07 2017-05-12 메사추세츠 인스티튜트 오브 테크놀로지 아미노알콜 리피도이드 및 그의 용도
WO2012135025A2 (en) 2011-03-28 2012-10-04 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
EP2882706A1 (en) 2012-08-13 2015-06-17 Massachusetts Institute of Technology Amine-containing lipidoids and uses thereof
US9315472B2 (en) * 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
WO2016004202A1 (en) 2014-07-02 2016-01-07 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
US10918742B2 (en) 2016-03-25 2021-02-16 Nanoprobes, Inc. Iodine-based particles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734953A (en) * 1969-08-11 1973-05-22 Squibb & Sons Inc Tris-triiodoisophthalamic acids and derivatives
NL7102816A (no) * 1970-03-12 1971-09-14
GB1346795A (en) * 1971-06-14 1974-02-13 Mallinckrodt Chemical Works Nitrilotriacyltriimino-tris-2,4,6-triidobenzoic acid compounds
AR207465A1 (es) * 1974-05-31 1976-10-08 Guerbet Lab Andre Procedimiento de preparacion de derivados de acido triiodoi2,4,6-(triiodo-2,4,6-benzoil)-amino-alcanoilaminobenzoico de acido triiodo-2,4,6-(triiodo-2,4,6-(triiodo-2,4,6-benzoil)-aminoalcanoilaminobenzoil)-amino-alcanoil-aminobenzoico y de acido triiodo-2,4,6-bis((triiodo-2,4,6-fenil)-carbamoil-metil)-aminoalcanoil-aminobenzoico
FR2511870A1 (fr) * 1981-08-28 1983-03-04 Guerbet Sa Procede pour augmenter la tolerance des produits opacifiants, composes utilisables a cet effet et produits opacifiants les contenant
US4507466A (en) * 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
ATE89743T1 (de) * 1986-08-18 1993-06-15 Dow Chemical Co Conjugate dichter sterne.
FR2635327B1 (fr) * 1988-08-10 1990-11-16 Guerbet Sa Polymeres iodes, a squelette dextrane, leurs procedes de preparation et leurs applications comme produits de contraste
CA2031739A1 (en) * 1989-12-08 1991-06-09 Milos Sovak X-ray contrast material for the gastrointestinal tract

Also Published As

Publication number Publication date
JPH07507572A (ja) 1995-08-24
IL108967A (en) 1999-01-26
US5817873A (en) 1998-10-06
FI945464A (fi) 1994-11-21
ATE173462T1 (de) 1998-12-15
NO944424D0 (no) 1994-11-18
IL108967A0 (en) 1994-06-24
ES2126101T3 (es) 1999-03-16
DE69414678T2 (de) 1999-07-22
ZA941959B (en) 1995-09-21
AU6285594A (en) 1994-10-11
FI945464A0 (fi) 1994-11-21
DE69414678D1 (de) 1998-12-24
NO307962B1 (no) 2000-06-26
CA2136243A1 (fr) 1994-09-29
EP0648203A1 (fr) 1995-04-19
HU218083B (hu) 2000-05-28
NO944424L (no) 1995-01-23
FR2703055B1 (fr) 1995-07-07
EP0648203B1 (fr) 1998-11-18
WO1994021600A1 (fr) 1994-09-29
HUT71474A (en) 1995-11-28
FR2703055A1 (fr) 1994-09-30

Similar Documents

Publication Publication Date Title
YU13794A (sh) Nova jedinjenja polijodida, njihovo pripremanje i njihova primena kao kontrast za rendgenska snimanja
Rothschild et al. Studies on albumin synthesis: The effects of dextran and cortisone on albumin metabolism in rabbits studied with albumin-I 131
Elliott Metabolism of lorazepam
KR900701326A (ko) 감염성 및 염증성 병변의 검색 및 치료법
GR3031659T3 (en) Enniatines and enniatine derivates used to control endoparasites.
Adlington et al. Applications of radical addition reactions to the synthesis of a C-glucoside and a functionalised amino-acid
WO1979000853A1 (en) Medicine for circulatory organ
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
HUT57994A (en) Radiopharmacological compositions and process for producing and administering them
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
JPS6429352A (en) Novel polycyclic aromatic compound, medicine and cosmetic composition
SG49239A1 (en) Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
DE69127541D1 (de) Pharmazeutische zusammensetzung
Perkins et al. Effect of pyrogen on phagocytic digestion and survival of X-irradiated mice
Ong et al. Hypersensitivity vasculitis complicating intravenous streptokinase therapy in acute myocardial infarction
Sack et al. Renal tolerance of impienem/cilastatin and other beta-lactam antibiotics in rats
Suk et al. The effects of thiamin on lead metabolism: whole body retention of lead-203
IL101626A (en) Synergistic preparations for the treatment of anxiety
EP0705110A4 (en) PERFUSION OF IMMUNOGLOBULINS IN HETEROGRAFTS
Müller et al. Prevention of chronic ITP?
Shaw THE INTRAVENOUS ADMINISTRATION OF MERCURY IN SYPHILIS
Gordon Anticoagulants in the treatment of myocardial infarction-a review
Gittoes et al. Heparin-induced thrombosis.
EP0500921A4 (en) Na-k-atpase inhibiting natriuretic substances
Malamos Studies of the retention and the elimination of radioactive iodine from the human body